Search clinical trials for: duloxetine

Total 388 results

Eli Lilly and Company

Completed

Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Depression

United States
Eli Lilly and Company

Completed

Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression

Depression

Austria
Eli Lilly and Company

Completed

Duloxetine Versus Paroxetine for Major Depression

Major Depressive Disorder

China
Eli Lilly and Company

Completed

Duloxetine Versus Placebo for Fibromyalgia

Fibromyalgia

United States
Eli Lilly and Company

Completed

Evaluation of the Effects of Duloxetine on Norepinephrine

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) (LEAPS)

Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

Depressive Disorder | Depression | Depressive Disorder, Major

United States
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Depression

France
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine vs Placebo in the Treatment of General Anxiety

Anxiety

United States
Eli Lilly and Company

Completed

Study of Duloxetine in Elderly Patients With Major Depressive Disorder

Depression | Cognition

United States
Eli Lilly and Company

Completed

Urge Incontinence Bladder Overactivity Study

Urinary Incontinence

United States, Australia, Canada
Eli Lilly and Company

Completed

Efficacy and Safety Stress Urinary Incontinence Study

Urinary Incontinence, Stress

Taiwan
Eli Lilly and Company

Completed

Duloxetine Stress Urinary Incontinence Efficacy and Safety Study

Urinary Incontinence, Stress

Korea, Republic of
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator for the Treatment of Depression

Depression

Canada
Eli Lilly and Company

Completed

A Study for the Treatment of Painful Diabetic Neuropathy

Diabetic Neuropathy, Painful

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study of Duloxetine in the Treatment of Fibromyalgia

Fibromyalgia

Argentina, Australia, Brazil, Canada, Mexico, Poland, Taiwan
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Depressive Disorder, Major

Belgium, Germany, France, Slovakia, Czech Republic, Finland
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Eli Lilly and Company

Completed

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Major Depressive Disorder

Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States

Search clinical trials for: duloxetine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations